会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Ibogamine congeners
    • Ibogamine同系物
    • US06211360B1
    • 2001-04-03
    • US09011809
    • 1998-08-31
    • Stanley D. GlickMartin E. Kuehne
    • Stanley D. GlickMartin E. Kuehne
    • C07D48718
    • C07D487/22A61K31/55
    • The present invention is directed to compounds having formula (1), wherein n is from 0 to 8; R1 is CH2OH, CH(OH)R5, CH2OR5, CO2R5, C(O)NH2, C(I)NHR5, C(O)NR5R6, C(O)NHNH2, C(O)NHNHR5, C(O)NHNR5R6, C(O)NR5NH2, C(O)NR5NHR6, C(O)NR5NR6R7, C(O)NHNH(C(O)R5), C(O)NHNR5(C(O)R6) C(O)NR5NH(C(O)R6), C(O)NR5NR6(C(O)R7), CN, or C(O)R5; R2 is H, unsubstituted or substituted alkyl, YH, YR8, YC(O)R8, C(O)YR8, C(O)NH2, C(O)NHR8, C(O)NR8R9, NH2, NHR8, NR8R9, NHC(O)R8, or NR8C(O)R9; R3 and R4 are the same or different and are selected from the group consisting of H, halogens, unsubstituted or substituted alkyl, OH, OR10, NH2, NHR10, NR10R11, NHC(O)R10, or NR10C(O)R11; R5, R6, R7, R8, R9, R10, and R11 are the same or different and are selected from the group consisting of unsubstituted alkyl and substituted alkyl and substituted alkyl; R12 is selected from the group consisting of J, unsubstituted alkyl, and substituted alkyl; and Y is O or S; provided that when n is O, R2 is selected from the group consisting of H, substituted alkyl, and unsubstituted alkyl; and pharmaceutically acceptable salts thereof. The compounds are useful in the treatment of subjects addicted to opiates and stimulants and have reduced side effects relative to other ibogamine congeners.
    • 本发明涉及具有式(1)的化合物,其中n为0至8; R 1是CH 2 OH,CH(OH)R 5,CH 2 OR 5,CO 2 R 5,C(O)NH 2,C(I)NHR 5,C(O)NR 5 R 6,C(O)NHNH 2,C(O)NHNHR 5,C(O)NHNR 5 R 6, C(O)NR 5 NH 2,C(O)NR 5 NR 6,C(O)NR 5 NR 6 R 7,C(O)NHNH(C(O)R 5),C(O)NHNR 5(C(O) (O)R 6),C(O)NR 5 NR 6(C(O)R 7),CN或C(O) R2是H,未取代或取代的烷基,YH,YR8,YC(O)R8,C(O)YR8,C(O)NH2,C(O)NHR8,C(O)NR8R9,NH2,NHR8,NR8R9,NHC (O)R 8或NR 8 C(O)R 9; R 3和R 4相同或不同,并且选自H,卤素,未取代或取代的烷基,OH,OR 10,NH 2,NHR 10,NR 10 R 11,NHC(O)R 10或NR 10 C(O)R 11; R5,R6,R7,R8,R9,R10和R11相同或不同,选自未取代的烷基和取代的烷基和取代的烷基; R 12选自J,未取代的烷基和取代的烷基; Y为O或S; 条件是当n是O时,R 2选自H,取代的烷基和未被取代的烷基; 和药学上可接受的盐